Fibrinogen (Octapharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFibrinogen (Octapharma)
Drug Alias NameFactor I concentrateFibrynaFibryga
ClassificationBiologics > Blood components
Mechanisms of ActionFibrinogen replacements
TargetsProthrombin
Therapy Area/IndicationsAfibrinogenemia
Global Approved IndicationsAfibrinogenemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/06/07
Country/TerritoryBulgariaCanadaUnited States +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsAfibrinogenemia
Inactive IndicationsN/A

Other Information

ATC CodeB02BB01